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Ras and Rap small GTPases are important for
synaptic plasticity and memory. However, their roles
in homeostatic plasticity are unknown. Here, we
report that polo-like kinase 2 (Plk2), a homeostatic
suppressor of overexcitation, governs the activity
of Ras and Rap via coordination of their regulatory
proteins. Plk2 directs elimination of Ras activator
RasGRF1 and Rap inhibitor SPAR via phosphoryla-
tion-dependent ubiquitin-proteasome degradation.
Conversely, Plk2 phosphorylation stimulates Ras
inhibitor SynGAPandRap activator PDZGEF1. These
Ras/Rap regulators perform complementary func-
tions to downregulate dendritic spines and AMPA
receptors following elevated activity, and their
collective regulation by Plk2 profoundly stimulates
Rap and suppresses Ras. Furthermore, perturbation
of Plk2 disrupts Ras and Rap signaling, prevents
homeostatic shrinkage and loss of dendritic spines,
and impairs proper memory formation. Our study
demonstrates a critical role of Plk2 in the synchro-
nized tuning of Ras and Rap and underscores the
functional importance of this regulation in homeo-
static synaptic plasticity.
INTRODUCTION
Homeostatic synaptic plasticity is proposed to restrain neuronal
firing within appropriate operating limits despite prolonged fluc-
tuations in network activity (Turrigiano, 2008). Attractive candi-
dates underlying adaptive responses to synaptic overexcitation
include activity responsive genes that exert negative feedback
control over synaptic activity or excitability (Shepherd and Huga-
nir, 2007). Polo-like kinase 2 (Plk2; also called SNK), an activity-
inducible member of the polo-like family of serine/threonine
kinases, is highly upregulated in central neurons by strong
synaptic stimulation (Kauselmann et al., 1999). Plk2 triggers
degradation of the dendritic spine-enriched protein SPAR viaphosphorylation-dependent ubiquitination (Pak and Sheng,
2003), leading to loss of mature spines and excitatory synapses
(Pak and Sheng, 2003; Seeburg et al., 2008). Furthermore, Plk2
is required for homeostatic adaptation in response to elevated or
epileptiform activity (Seeburg and Sheng, 2008). Thus, Plk2
exerts physiological and morphological downregulation of excit-
atory synapses following heightened activity, at least in part by
depletion of SPAR, a negative regulator of Rap small GTPases
(Pak et al., 2001).
Rap andRas are closely relatedmolecular switches occupying
central but often opposing roles in synaptic plasticity (Ye and
Carew, 2010). Ras promotes long-term potentiation (LTP) and
surface delivery of AMPA receptors (AMPARs), whereas Rap
mediates long-term depression (LTD) or depotentiation and
AMPAR internalization (Zhu et al., 2002; Zhu et al., 2005). Ras
also stimulates overproduction of dendritic protrusions or spines
(Arendt et al., 2004; Wu et al., 2001), while Rap promotes spine
loss (Fu et al., 2007; Pak et al., 2001; Ryu et al., 2008). Numerous
synaptic regulators of Ras/Rap have been identified, including
activators (guanine nucleotide exchange factors [GEFs] that
stimulate exchange of bound GDP for GTP) and inactivators
(GTPase activating proteins [GAPs] that accelerate intrinsic
GTPase activity to hydrolyze bound GTP to GDP). The Rap
GAPSPAR and the RasGAPSynGAPboth interact with the scaf-
fold protein PSD-95 in the postsynaptic density (PSD) (Chen
et al., 1998; Kim et al., 1998; Pak et al., 2001). SPAR promotes
spine growth (Pak et al., 2001), while SynGAP deficiency hyper-
activates the Ras effector ERK, increases AMPAR surface clus-
ters, and enlarges dendritic spines (Kim et al., 2003; Komiyama
et al., 2002; Vazquez et al., 2004), supporting the idea that Ras
drives spine growth in opposition to Rap.
Additionally, the Ras GEF RasGRF1/CDC25Mm interacts
with NMDA receptor (NMDAR) subunit GluN2B and is required
for memory consolidation (Brambilla et al., 1997) and NMDA-
dependent ERK activation (Krapivinsky et al., 2003). PDZGEF1
(or RapGEF2/nRapGEP/CNrasGEF/RA-GEF), a neural-specific
activator for both mammalian Rap proteins Rap1 and Rap2 (de
Rooij et al., 1999; Liao et al., 1999), associates with synaptic
scaffolding protein S-SCAM (Ohtsuka et al., 1999), but
PDZGEF1 function at synapses is unclear.
Here, we report that Plk2 phosphorylates a quartet of Ras
and Rap regulators: SynGAP, PDZGEF1, RasGRF1, and SPAR,Neuron 69, 957–973, March 10, 2011 ª2011 Elsevier Inc. 957
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activity. These GEFs and GAPs cooperate to downregulate
excitatory synapses, dendritic spines, and surface AMPARs
following chronic overexcitation. Furthermore, perturbation of
Plk2 function disrupts Ras and Rap signaling cascades, abol-
ishes overactivity-dependent synaptic remodeling, and impairs
memory formation. These findings show that coordinated regu-
lation of Ras and Rap by Plk2 is critical for homeostatic plasticity
and memory.
RESULTS
To identify additional Plk2 substrates, we tested a panel of
synaptic proteins for modification by cotransfected Plk2 in
COS-7 cells. Candidates included PSD-95, SAP97, Chapsyn-
110, GKAP, AMPAR subunits GluA1/A2, NMDAR subunits
GluN1/N2B, Shank, CRIPT, CASK, a-actinin, liprin a1, Epac,
Epac2, and Repac, but none of these candidates were reproduc-
ibly affected by Plk2 (Figures S1A and S1B, available online; data
not shown). The only proteins strongly modified were RasGRF1,
SynGAP, PDZGEF1, and SPAR (Figures 1A–1D and Figure S1C).
With SynGAP and PDZGEF1, Plk2 caused pronounced SDS-
PAGE gel mobility shifts without changes in total expression,
suggestive of phosphorylation (Figures 1A and 1B). Indeed,
constitutively active (CA) Plk2 mutant T236E (Ma et al., 2003b)
caused greater gel shift than did wild-type (WT) Plk2 (Figure 1A),
while Plk2 kinase-dead (KD) mutant K108M had no effect on
SynGAP or any of the candidates (Figures 1A–1D). Treatment
of immunoprecipitated SynGAP with calf intestinal alkaline
phosphatase abolished its gel shift (Figure S1D), confirming
phosphorylation of SynGAP.
Plk2 contains an N-terminal kinase domain and conserved
C-terminalpoloboxdomain (PBD) thatmediatessubstrate recog-
nition and subcellular targeting (Lee et al., 1998). As expected,
neither the kinase domain nor PBDaloneaffectedSynGAPmigra-
tion, suggesting that efficient phosphorylation of SynGAP
requires PBD-mediated substrate recruitment (Figure 1A).
In contrast to SynGAP and PDZGEF1, Plk2 dramatically
reduced steady-state protein levels of RasGRF1 and SPAR in
a dose-dependent manner, consistent with target degradation
(Figures 1C and 1D and Figure S1C). Loss of RasGRF1 in pres-
ence of CA Plk2 could be largely blocked by proteasome inhib-
itor MG132 (Figure 1C), similar to Plk2-mediated degradation of
SPAR (Pak and Sheng, 2003). Furthermore, KD Plk2 competi-
tively inhibited WT Plk2 from degrading SPAR in a dominant-
negative manner (Figure S1E).
To demonstrate direct phosphorylation by Plk2, we immuno-
precipitated RasGRF1, SynGAP, PDZGEF1, or SPAR singly
expressed in COS-7 cells (Figure 1E) for in vitro kinase reactions.
Immunoprecipitates were incubated with 32P-g-ATP and bacte-
rially purified CA or KD Plk2 fused to glutathione-S-transferase
(GST). CA Plk2, but not KD Plk2, robustly phosphorylated each
of these Ras/Rap regulators in this defined system, while nega-
tive controls liprin a1 and GFPwere unaffected (Figure 1F). Thus,
the identified Ras/Rap GEFs and GAPs were all direct Plk2
substrates.
In addition, as previously shown for SPAR (Pak and Sheng,
2003), endogenous RasGRF1, SynGAP, and PDZGEF1 from958 Neuron 69, 957–973, March 10, 2011 ª2011 Elsevier Inc.mouse brain lysates were each coimmunoprecipitated by rabbit
anti-Plk2 antibody, but not by IgG (Figure 1G), indicating Plk2
associated with the identified GEFs/GAPs of Ras and Rap
in vivo. Plk2 could also be coimmunoprecipitated with each
regulator when cotransfected in COS-7 cells (Figures 1H–1J),
again similar to Plk2 interaction with SPAR (Pak and Sheng,
2003).
Plk2 Is Required for Overactivity-Dependent Loss
of RasGRF1 and SPAR
To investigate the functional significance of Plk2 phosphoryla-
tion of GEFs/GAPs, we confirmed that each Ras/Rap regulator
was found in a punctate distribution at excitatory synapses,
colocalized with PSD-95, and apposed to the presynaptic
marker synaptophysin (Figure S2A–S2D; data not shown). To
determine whether Plk2 induction could degrade endogenous
RasGRF1, we treated cultured hippocampal neurons with picro-
toxin (PTX, 100 mM, 24 hr), a GABAA receptor antagonist that
potently induces Plk2 protein expression (Pak and Sheng,
2003) (also see Figures S4B and S4C). PTX-treated neurons
exhibited profound loss of both RasGRF1 and SPAR immunore-
activities (Figures 2A–2C) (19% ± 3% of RasGRF1 and 37% ±
5% of SPAR compared to vehicle) in proximal dendrites where
Plk2 is enriched (Pak and Sheng, 2003), but not in distal
dendrites (Figured 2A–2C). Transfection of Plk2 also decreased
fluorescent intensity of RasGRF1 (38% ± 6%) and SPAR
(23% ± 6%) to a similar degree as PTX treatment (Figures 2D–
2F). These results demonstrated that elevated Plk2 was suffi-
cient to deplete RasGRF1 and SPAR in specific dendritic regions
of hippocampal neurons.
To test whether Plk2 was required for overactivity-dependent
degradation of RasGRF1 and SPAR, we employed three inde-
pendent methods to inhibit Plk2 function: (1) KD Plk2, a domi-
nant-negative inhibitor of WT Plk2 (Figure S1E); (2) BI2536,
a potent and selective inhibitor of Plk family kinases (Plks 1–4)
(Le´na´rt et al., 2007); and (3) RNA interference (RNAi) to specifi-
cally and effectively silence Plk2 expression (Figures S4A–
S4D). As above, PTX caused extensive loss of RasGRF1 and
SPAR in proximal dendrites relative to basal control, along with
more modest decreases in PSD-95: GFP-expressing neurons
(RasGRF1, 23% ± 5%; SPAR, 26% ± 7%; PSD-95, 40% ± 4%)
(Figures 2G and 2H); no BI2536 (RasGRF1, 21% ± 3%; SPAR,
27% ± 4%; PSD-95, 32% ± 5%) (Figures 2I and 2J); and
transfected with empty pLL3.7 vector (RasGRF1, 23% ± 7%;
SPAR, 13% ± 3%; PSD-95, 34% ± 5%) (Figures 2K and 2L).
For PSD-95, puncta number was highly correlated with inte-
grated intensity values (Figure S2E–S2G), suggesting decreases
in PSD size as well as number, supported also by immunofluo-
rescent intensity and puncta density for another postsynaptic
marker, Shank (Figures S2H–S2J). Because Plk2 did not affect
PSD-95 expression in COS-7 cells (Figure S1A), the dismantling
of PSD scaffold proteins in neurons was probably indirect.
In contrast, blocking Plk2 function or expression fully abol-
ished these responses to PTX: expression of KD Plk2 (RasGRF1,
109% ± 28%; SPAR, 102% ± 15%; PSD-95, 90% ± 8%; p >
0.41) (Figures 2G and 2H); treatment with BI2536 (75 nM,
20 hr) (RasGRF1, 86% ± 6%; SPAR, 105% ± 13%; PSD-95,
108% ± 24%; p > 0.29) (Figures 2I and 2J); and knockdown of
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Figure 1. Plk2 Interacts with and Phosphorylates Ras and Rap GEFs/GAPs
(A) Gel mobility shift of SynGAP induced by cotransfected wild-type (WT) or constitutively active (CA) Plk2 in COS-7 cells, but not by kinase-dead (KD) Plk2 or Plk2
N/C-terminal fragments.
(B) Gel mobility shift of PDZGEF1 by cotransfected CA Plk2 but not KD Plk2.
(C) RasGRF1 was cotransfected with KD or CA Plk2 in COS-7 cells and treated with MG132 (25 mM, 16 hr) or vehicle (DMSO), and lysates were immunoblotted
as shown at right of blots.
(D) COS-7 cells were transfected with SPAR and KD or CA Plk2. Cotransfected liprin was used as internal negative control and transfection/loading control.
(E) Proteins as indicated at top were immunoprecipitated 24 hr after transfection and recovery examined by immunoblotting. In, input; IP, immunoprecipitation.
(F) Immunoprecipitates from (E) were incubated with 32P-g-ATP and purified KD or CA Plk2 (except in last lane, containing CA Plk2 only). Black dots indicate
expected sizes of indicated proteins. Autophosphorylated CA Plk2 (auto) was marked with asterisks. Liprin and GFP were used as negative controls. Note:
right-most panel was run on higher-percentage gel to resolve GFP.
(G) Mouse brain lysates (Input) were immunoprecipitated with rabbit anti-Plk2 antibody (7382) or IgG control and immunoblotted for Ras/Rap regulators
as indicated.
(H–J) COS-7 cells were transfected as indicated at top of blots, with IP performed as shown at bottom and western blotting for transfected proteins as indicated
at right of each blot. KD Plk2 was used in (J) to prevent loss of RasGRF1 by active Plk2. Input, 10% of lysate used for each IP. All MW in kDa.
Neuron
Regulation of Ras and Rap Signaling by Plk2Plk2 (RasGRF1, 154% ± 26%; SPAR, 128% ± 14%; PSD-95,
134% ± 5%; p > 0.38) (Figures 2K and 2L). To control for RNAi
off-target effects, we coexpressed Plk2-shRNA with an shRNA-
resistant rescue construct of Plk2 (Figures S4A and S4E) and
observed significantly reduced fluorescent intensity or puncta
number of RasGRF1, SPAR, and PSD-95 (Figures S4E–S4G),
similar to the effect of WT Plk2 overexpression alone. Interest-
ingly, knockdown of the highly related polo-like kinase Plk3
with a specific shRNA construct (Figure S4H–S4K) had no effecton PTX-mediated loss of synaptic proteins (Figures S4L and
S4M), suggesting a specific role for Plk2 in this process.
Although expression of KD Plk2 (Figure 2D–2F) or knockdown
of Plk2 for 3 days in the absence of PTX caused a significant
overaccumulation in RasGRF1, SPAR, PSD-95, and Shank
levels (Figures 2F and L and Figures S2I and S2J) (KD Plk2:
RasGRF1, 148% ± 24%; SPAR, 165% ± 15%; Shank, 150% ±
14%; Plk2 RNAi: RasGRF1, 169% ± 24%; SPAR, 147% ± 16%;
PSD-95, 139% ± 11%; p < 0.05), BI2536 treatment alone forNeuron 69, 957–973, March 10, 2011 ª2011 Elsevier Inc. 959
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Figure 2. Plk2 Induced by Overactivity Eliminates RasGRF1 and SPAR in Neurons
(A and B) Cultured hippocampal neurons (20–23 DIV) were treated with PTX (100 mM, 20 hr) or vehicle and immunolabeled for RasGRF1 and SPAR.MAP2 staining
is shown to outline dendrites. Scale bar represents 20 mm.
(C) Quantification of integrated intensity of RasGRF1 and SPAR (n = 10).
(D and E) Neuronswere transfectedwith pEGFP,WT Plk2, or KDPlk2 for 3 days followed by immunostaining for RasGRF1 and SPAR. Scale bar represents 10 mm.
(F) Quantification of integrated intensity of RasGRF1 and SPAR in proximal dendrites (n = 10).
(G) Hippocampal cultures were infected with Sindbis virus expressing GFP,WT Plk2, or KD Plk2, treated with PTX, then immunostained for RasGRF1, SPAR, and
PSD-95. Scale bar represents 10 mm.
(H) Quantification of integrated intensity from (G) in proximal dendrites (n = 10–11).
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Regulation of Ras and Rap Signaling by Plk220 hr did not (Figure 2J and Figure S2F) (RasGRF1, 102%± 14%;
SPAR, 110% ± 14%; PSD-95, 111% ± 13%; p > 0.52), probably
due to the shorter length of time of Plk2 inhibition.
Moreover, PTX effects were occluded in neurons expressing
WT Plk2 (RasGRF1, 20% ± 4%; SPAR, 24% ± 3%; PSD-95,
33% ± 5%; p < 0.001 for each versus GFP and p > 0.28 versus
GFP+PTX) (Figures 2G and 2H and Figure S2E), indicating that
Plk2 and PTX operate by overlapping mechanisms. Collectively,
these data demonstrated a specific requirement for Plk2 in
homeostatic removal of RasGRF1, SPAR, and excitatory
synaptic scaffolding following chronic overactivity.
Plk2 Promotes SynGAP and PDZGEF1 Activity
Because Plk2 phosphorylated SynGAP and PDZGEF1 without
reducing their expression, we examined their enzymatic activity
against Ras and Rap. We used GST linked to the Ras binding
domain (RBD) of the Ras effector Raf1 as an affinity reagent
that specifically pulls down active Ras (de Rooij and Bos,
1997) (Figure S3A). With this assay we found that SynGAP
modestly reduced activity of cotransfected WT H-Ras, as ex-
pected (Figures 3A and 3B) (Kim et al., 1998). Levels of active
Ras were further diminished when SynGAP and Ras were co-
transfected with Plk2 (Figures 3A and 3B). Plk2 by itself had no
effect on Ras, indicating that Plk2 exerted regulation of Ras via
SynGAP (mean density: Ras, 0.48 ± 0.03; Ras+SynGAP, 0.35 ±
0.03, p < 0.05; Ras+SynGAP+Plk2, 0.21 ± 0.02, p < 0.001 versus
Ras alone and p < 0.05 versus Ras+SynGAP; Ras+Plk2, 0.54 ±
0.09, p = 0.58).
Similarly, active Rap pull-down assays were carried out using
GST fused to the Rap binding domain of RalGDS, a downstream
effector of Rap (Zwartkruis et al., 1998) that bound only to active
Rap (Figure S3B). When WT Rap2 was transfected alone, only
a small amount of active Rap2 was observed (Figure 3C). Co-
transfection of PDZGEF1 significantly stimulated Rap2 activity,
consistent with Rap GEF function (de Rooij et al., 1999). Levels
of active Rap2 were further boosted when Plk2 was cotrans-
fected with PDZGEF1 and Rap2 (Figures 3C and 3D). Plk2 by
itself did not affect active Rap2 levels, suggesting that Plk2
activated Rap by enhancing the GEF activity of PDZGEF1
(mean density: Rap2, 0.15 ± 0.06; Rap2+PDZGEF1, 0.59 ±
0.11, p < 0.01; Rap2+PDZGEF1+Plk2, 1.15 ± 0.11, p < 0.001
versus Rap2 alone and p < 0.01 versus Rap2+PDZGEF1; Rap2+
Plk2, 0.26 ± 0.09, p = 0.36). Thus, Plk2 was sufficient to promote
the activities of both SynGAP and PDZGEF1 in mammalian cells.
Plk2 Is Required for Overactivity-Dependent Regulation
of Ras and Rap
To directly test effects of Plk2 on Ras and Rap in neurons, we in-
fected hippocampal neurons with Sindbis virus expressing
EGFP, WT Plk2, or KD Plk2 for 24 hr and then performed active(I) Neurons were treated with PTX in the presence of Plk inhibitor BI2536 (75 nM, 2
PSD-95. Scale bar represents 10 mm.
(J) Quantification of integrated intensity from (I) in proximal dendrites (n = 10).
(K) Hippocampal neurons were transfected with Plk2-shRNA or control (pLL3.7) v
RasGRF1, SPAR, and PSD-95. Scale bar represents 10 mm.
(L) Quantification of integrated intensity from (K) (n = 10). *p < 0.05, **p < 0.01, **
All error bars represent standard error of the mean (SEM).Ras and Rap pull-down assays. Remarkably, neurons express-
ing WT Plk2 showed nearly a complete absence of active
Ras, along with much higher levels of active Rap2 compared
to cultures expressing GFP or KD Plk2 (Figures 3E and 3F), re-
sulting in 110-fold change in the relative activity of Rap versus
Ras (Figure 3G; p < 0.05) (active Ras: GFP, 0.28 ± 0.03; WT Plk2,
0.02 ± 0.01, p < 0.001; KD Plk2, 0.33 ± 0.08, p = 0.61; active
Rap2: GFP, 0.09 ± 0.02; WT Plk2, 0.68 ± 0.11, p < 0.01; KD
Plk2, 0.11 ± 0.01, p = 0.29). Plk2 overexpression also markedly
reduced activation of the downstream Ras target ERK and
increased active p38 (a Rap target) compared to GFP-express-
ing or untransfected neurons (Figures S3C–S3F). Conversely,
KD Plk2 expression significantly increased phospho-ERK (Fig-
ure S3D) but did not affect phospho-p38 (Figure S3F).
Induction of endogenous Plk2 by PTX treatment of neurons
also decreased active Ras levels while elevating levels of active
Rap (Figures 3H and 3I) (8.6-fold increase in relative Rap versus
Ras activity; Figure 3J; p < 0.01) (active Ras: control, 0.47 ± 0.03;
PTX, 0.16 ± 0.03, p < 0.01; BI2536+PTX, 0.49 ± 0.05, p = 0.83;
active Rap2: control, 0.14 ± 0.02; PTX, 0.40 ± 0.02, p < 0.001;
BI2536+PTX, 0.15 ± 0.01, p = 0.67). These PTX-mediated effects
were blocked by coincubation with Plk inhibitor BI2536 (Figures
3H–3J), suggesting that native Plk2 directs overactivity-depen-
dent bidirectional shifts in Ras and Rap signaling.
Plk2 Is Required for Overactivity-Dependent Spine
Remodeling
Plk2 induction promotes elimination of mature dendritic spines
(Pak and Sheng, 2003). To examine whether loss of Plk2 affected
spine morphology, we transfected neurons with Plk2-shRNA.
Plk2 knockdown for 3 days significantly increased spine density
and spine head size in proximal dendrites compared to control
(Figures 4A and 4C) and also blocked PTX-induced decreases
in spine density and head area (Figures 4B and 4D; quantified in
Figures F and 4G and Table S1). Coexpression of the Plk2 rescue
construct suppressed the Plk2-shRNA phenotypes and further
decreased spine density and head size below control values
(Figures 4E–4G). Moreover, acute disruption of Plk2 function
using BI2536 also prevented PTX-dependent reduction in spine
density and head width (Figures 4H–4M; Table S1). However,
we did not observe increased spine number or head size in
neurons treated with BI2536 by itself for 20 hr, again possibly
reflecting the difference between acute and chronic disruption
of Plk2 function.No significant differenceswere detected in spine
length under any conditions (Table S1). We also did not observe
changes in spine density and morphology in distal dendrites of
PTX-treated neurons (Figure S4N–S4Q), consistent with our
immunostaining results (Figures 2A–2C). These data demon-
strated that Plk2 is critical for homeostatic downregulation of
proximal dendritic spines following overactivity.0 hr) or vehicle as indicated and then immunostained for RasGRF1, SPAR, and
ector. After 48 hr, cells were treated with PTX or vehicle and immunolabeled for
*p < 0.001 for all graphs.
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Figure 3. Plk2 Stimulates SynGAP and PDZGEF1
to Regulate Ras and Rap
(A) COS-7 cells were transfected as indicated at top of
blot. Cell lysates were incubated with GST-Raf1-RBD to
precipitate active Ras, followed by immunoblotting (IB)
as indicated.
(B)Quantification of activeRasnormalized to total Ras (n = 6).
(C) Lysates of COS-7 cells transfected as indicated at top
were incubated with GST-RalGDS-RBD to precipitate
active Rap, followed by IB analysis.
(D) Quantification of active Rap2 normalized to total Rap2
(n = 6).
(E) Active Ras and Rap pull-down assays in cultured
hippocampal neurons. Cells (19–21 DIV) were infected
with Sindbis virus expressing GFP, WT Plk2, or KD Plk2.
GST-Raf1-RBD and GST-RalGDS-RBD were used to pull
down active Ras and Rap, respectively.
(F) Quantification of active H-Ras and Rap2 normalized
to total expression (n = 5 and 7, respectively).
(G) Relative fold change in Rap versus Ras activity.
(H) Hippocampal neurons were stimulated with PTX in the
presence or absence of BI2536. Active Ras and Rap pull-
down assays were performed with GST-Raf1-RBD and
GST-RalGDS-RBD.
(I) Quantification of active H-Ras and Rap2 normalized
to total expression (n = 3–4).
(J) Relative fold change in Rap versus Ras activity.
*p < 0.05, **p < 0.01, ***p < 0.001 for all graphs.
All error bars represent SEM.
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Regulation of Ras and Rap Signaling by Plk2Ras and Rap Regulators Are Essential for Plk2-Induced
Spine Remodeling
To determine the roles and relative importance of individual Ras/
Rap regulators in Plk2-directed spine plasticity, we first trans-
fected hippocampal neurons with GFP-expressing shRNA
constructs generated against each regulator (Figure S5F; knock-
down efficiency shown in Figures S5A–S5E). Quantitative anal-
ysis of proximal dendritic spines showed distinct effects for
each regulator. RasGRF1 knockdown significantly reduced
spine density and length compared to control vector, while
silencing of SPAR reduced head width and spine density (Fig-
ure S5G–S5I; Table S1). Loss of SynGAP greatly increased spine
head size with no change in other parameters, and PDZGEF1
RNAi increased only spine density (Figures S5G–S5I; Table S1).
These changes in spine head size and number were highly962 Neuron 69, 957–973, March 10, 2011 ª2011 Elsevier Inc.correlated with the results of immunofluores-
cent intensity and puncta density for PSD-95
(data not shown). Moreover, coexpression of
shRNA-resistant rescue constructs completely
prevented the spine phenotypes observed with
silencing their cognate Ras/Rap regulators
(Figures S5F–S5I; Table S1), demonstrating
RNAi specificity. Thus, the Ras/Rap regulatory
proteins govern overlapping but non-identical
aspects of dendritic spines (Figure S5J).
Because Plk2 degraded RasGRF1/SPAR
while stimulating SynGAP/PDZGEF1, we rea-
soned that overexpression of RasGRF1/SPAR,
or silencing of SynGAP/PDZGEF1, may block
Plk2-induced reduction in spine density andhead width (Figures 5A, 5B, 5G, and 5H). Indeed, coexpression
of either RasGRF1 or SPAR with Plk2 increased spine density
and head size compared to Plk2 alone (Figures 5C and 5F–5H;
Table S1). Knockdown of SynGAP in the presence of Plk2 mark-
edly increased spine head width (Figures 5D and 5H) with no
change in spine density (Figure 5G), while silencing of PDZGEF1
with Plk2 expression increased spine number without change in
spine head size (Figures 5E, 5G, and 5H; Table S1). Thus, reduc-
tion of RasGRF1/SPAR and enhancement of SynGAP/PDZGEF1
all contribute to Plk2 effects on spines (Figure 5I).
We further tested whether modulation of Ras/Rap regulation
could rescue the increased spine density and headwidth caused
by Plk2 RNAi (Figures 5J, 5K, 5P, and 5Q; Table S1). Knockdown
of Plk2 increases RasGRF1/SPAR levels and is predicted to
decrease SynGAP/PDZGEF1 activity; therefore, silencing of
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Figure 4. Requirement for Plk2 in Chronic Overactivity-Dependent
Spine Remodeling
(A–E) Cultured hippocampal neurons (21 DIV) were transfected with control
vector (pLL3.7) containing CMV-EGFP, Plk2-shRNA, or Plk2-shRNA plus
rescue construct. After 48 hr, cells were treated with PTX or vehicle and
immunolabeled against GFP. Scale bar represents 5 mm.
(F) Quantification of spine density (n = 10–11, *p < 0.05, **p < 0.01).
(G) Cumulative frequency plot of spine head area (n = 262–357 spines;
Kolmogorov-Smirnov (K-S) test; Table S1).
(H–K) Neurons were transfected with EGFP plasmid. After 48 hr, cells were
treated with or without PTX in the presence of BI2536 or vehicle and then
immunostained for GFP. Scale bar represents 5 mm.
(L) Quantification of spine density (n = 12, ***p < 0.001).
(M) Cumulative frequency plot of spine head width (n = 200 spines; K-S test;
Table S1).
All error bars represent SEM.
Neuron
Regulation of Ras and Rap Signaling by Plk2RasGRF1/SPAR or overexpression of SynGAP/PDZGEF1 may
be expected to reverse the effects of Plk2 RNAi. Silencing of
RasGRF1 and Plk2 together reduced spine density to control
level, although spine head width remained similar to Plk2 knock-
down alone (Figures 5L, 5P, and 5Q; Table S1). Knockdown of
SPAR and Plk2 together showed a significant decrease in both
spine density and head width (Figures 5O–5Q). Cotransfection
of SynGAP with Plk2-shRNA markedly decreased spine head
size without change in spine density (Figures 5M, 5P, and 5Q),
whereas coexpression of PDZGEF1 with Plk2-shRNA reducedspine density without change in head width (Figures 5N, 5P,
and 5Q). No significant differenceswere observed in spine length
in any condition (Table S1). Collectively, these data demonstrate
that Ras/Rap GEFs and GAPs act downstream of Plk2 and
further support the idea that different regulators control specific
aspects of spine morphology and density (Figures 5I and 5R).
Plk2 Phosphorylation of Ras/Rap Regulators Is
Required for Overactivity-Dependent Spine Remodeling
To determine the requirement for Plk2 phosphorylation of
Ras/Rap regulators in spine morphogenesis, we identified
Plk2-dependent phosphorylation sites in target substrates using
tandem mass spectrometry. In total, we detected six sites for
RasGRF1, eight sites for SynGAP, and five sites for PDZGEF1
that were specifically phosphorylated in the presence of active
Plk2 (Figure S6A).
We next tested whether RasGRF1 phosphorylation was
required for its degradation by Plk2. COS-7 cells were trans-
fected with WT or phosphomutants of RasGRF1 and either KD
or CA Plk2. As before, WT RasGRF1 levels were greatly dimin-
ished by active Plk2 (Figure S6B). However, mutation of either
serine 71 or 575 to alanine (S71A or S575A) substantially
abolished loss of RasGRF1 by Plk2 (Figure S6B). Intriguingly,
both mutants reside within RasGRF1 pleckstrin homology (PH)
domains, motifs that mediate membrane association (Buchs-
baum et al., 1996). Indeed, the phosphomutants displayed
higher enrichment in membrane fractions (Figure S6C), suggest-
ing that Plk2 phosphorylation of RasGRF1 PH domains causes
membrane dissociation as a prelude to degradation.
For SynGAP, either of two phosphomutants (S781A or S783A)
largely blocked the gel mobility shift induced by Plk2 (Fig-
ure S6D), implying a critical role of these adjacent phosphosites
for conformational changes in SynGAP. Active Ras pull-down
assays demonstrated that these sites, as well as S326 and
S390, were also crucial for Plk2 to stimulate SynGAP activity
against Ras (Figures S6E and S6F; Table S2).
In the case of PDZGEF1, we observed no differences in Plk2-
dependent gel mobility shift or alterations in Rap GEF activity
with any single Plk2 phosphosite mutant (Figure S6G). Various
double, triple, and quadruple phosphomutant combinations of
PDZGEF1 also yielded no effect on mobility shift or GEF activity
(data not shown). However, loss of all five Plk2 phosphosites
(5xAmutant) substantially blocked themobility shift of PDZGEF1
by Plk2 (Figure S6G, right panel) and the Plk2-mediated increase
in enzymatic activity of PDZGEF1 toward Rap (Figures S6H and
S6I; Table S2).
Next, to evaluate the functional importance of these phospho-
sites for overactivity-dependent spine remodeling, we per-
formed quantitative spine analysis in proximal dendrites of
neurons expressing the most severe mutants of RasGRF1
(S71A), SynGAP (S390A or S783A), and PDZGEF1 (5xA) (Fig-
ure 6A). Transfection of either WT or RasGRF1 (S71A) increased
spine density compared to GFP control (Figures 6B–6D and 6J;
Table S1). PTX application significantly reduced spine density in
neurons expressing WT RasGRF1, but this effect was partially
blocked in neurons expressing RasGRF1 (S71A) (Figures 6C,
6D, and 6J). WT RasGRF1 also increased spine head size, which
was reversed in the presence of PTX (Figure 6K). In contrast, PTXNeuron 69, 957–973, March 10, 2011 ª2011 Elsevier Inc. 963
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Figure 5. Plk2-Induced Spine Remodeling Is Mediated by Ras- and Rap-GEFs/GAPs
(A–F) Hippocampal neurons (21 DIV) were transfected as indicated, along with pEGFP to visualize spine morphology. After 3 days, cells were immunostained for
GFP. Scale bar represents 5 mm.
(G) Quantification of spine density from (A–F) (n = 10–11, *p < 0.05, **p < 0.01, ***p < 0.001).
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Regulation of Ras and Rap Signaling by Plk2treatment failed to reduce spine head width in neurons express-
ing RasGRF1 (S71A) (Figure 6K).
Expression of WT or phosphomutants of SynGAP strongly
reducedspineheadsize (Figures6E–6Gand6L;TableS1)without
changing spine density. PTX treatment of neurons expressingWT
SynGAP led to even further reduction of head width as well as
spine loss (perhaps due to some spine sizes falling below the
cutoff threshold for detection) (Figures6E, 6J, and6L). In contrast,
these PTX effects were abolished in neurons expressing either
SynGAP phosphomutant (Figures 6F, 6G, 6J, and 6L).
Lastly, either WT or PDZGEF1 (5xA) mutant decreased spine
density without changing head size (Figures 6H–6J and 6M;
Table S1). PTX treatment further decreased spine density in
neurons expressing WT PDZGEF1, but not in neurons express-
ing the quintuple phosphomutant (Figures 6H–6J). However,
neither WT nor PDZGEF1 (5xA) mutant affected PTX-dependent
reduction of spine head size (Figure 6M). There was no signifi-
cant difference in spine length in any condition (Table S1).
Together, these results suggested that phosphorylation of Ras/
Rap regulators by Plk2 is required for homeostatic regulation
of dendritic spines following chronic overactivity.
Plk2 Phosphorylation of Ras/Rap Regulators Controls
Surface AMPARs
We recently showed that Plk2 promotes loss of surface GluA2
(sGluA2) via an atypical kinase-independent mechanism in
distal dendrites (Evers et al., 2010). To elucidate the role of
Plk2 phosphorylation in AMPAR surface expression, we stimu-
lated neuronal activity while blocking Plk2 kinase activity (with
BI2536) or Plk2 expression (with Plk2-RNAi). PTX treatment
markedly decreased surface GluA1 (sGluA1) expression only in
proximal dendrites, with no change in distal dendrites, and this
decrease was abolished by either BI2536 or Plk2 RNAi (Figures
7A and 7C). In contrast, PTX reduced sGluA2 in both proximal
and distal dendrites (Figures 7B and 7D), consistent with
previous findings (Evers et al., 2010). Interestingly, coincubation
of BI2536 with PTX rescued sGluA2 expression only in proximal
dendrites, but not distal dendrites, while Plk2 RNAi increased
basal sGluA2 expression in both proximal and distal dendrites
and abolished PTX-induced removal of sGluA2 in either region
(Figures 7B and 7D). No changes in total GluA1/A2 were
observed under any conditions (data not shown and Evers
et al., 2010). Thus, sGluA1/A2 on proximal dendrites were regu-
lated by a Plk2 kinase-dependent mechanism, whereas the
kinase-independent mechanism specifically affected sGluA2 in
distal dendrites.
We next examined the role of Ras/Rap regulators in overac-
tivity-induced reduction of AMPARs. Cultured neurons were
transfected with shRNA against RasGRF1 or SPAR in the
absence of synaptic stimulation to test whether inactivation of(H) Cumulative frequency plot of spine head width (n = 150–200 spines; K-S test
(I) Summary of spine remodeling. Plk2 was compared to GFP control, while othe
(J–O) Cultured neurons were transfected as indicated for 3 days, followed by im
(P) Quantification of spine density from (J–O) (n = 10–11, *p < 0.05, **p < 0.01, **
(Q) Cumulative frequency plot of spine head width (n = 150–250 spines; K-S test
(R) Summary of spine remodeling. Plk2 RNAi was compared to control vector (p
All error bars represent SEM.Ras or activation of Rap is sufficient to cause loss of surface
AMPARs. As expected, knockdown of SPAR reduced sGluA1/
A2 expression in proximal dendrites (Figures 7E–7H). Silencing
of RasGRF1also decreased sGluA1 but only showed a nonsignif-
icant trend for sGluA2 removal (Figures 7E–7H, p = 0.10). We
then transfected neurons with shRNA constructs for SynGAP
or PDZGEF1 and stimulated with PTX to induce endogenous
Plk2. PTX-mediated loss of sGluA1/A2 was completely abol-
ished by silencing SynGAP or PDZGEF1 (Figures 7E–7H). These
results demonstrate that tuning down of Ras or tuning up of Rap
is necessary and sufficient for PTX-induced reduction of
AMPARs in proximal dendrites.
Finally, we investigated whether Plk2 phosphorylation of
Ras/Rap regulators is important for the PTX effects on surface
AMPARs. As before, PTX stimulation reduced sGluA1/A2
levels in proximal dendrites (Figures 7I–7L). Overexpression of
RasGRF1 WT or its phosphomutant (S71A) significantly in-
creased sGluA1 expression, and the sGluA1 loss by PTX was
partially blocked in neurons expressing S71A (Figures 7I and
7K). In contrast, RasGRF1 expression did not increase sGluA2
levels or prevent PTX-mediated removal of sGluA2 (Figures 7J
and 7L), confirming the above result that silencing of RasGRF1
did not greatly reduce sGluA2 (Figures 7G and 7H). Expression
of SynGAP WT or PDZGEF1 WT reduced sGluA1/A2, and there
was further reduction of sGluA1/A2 after PTX stimulation (Figures
7I–7L). Phosphomutants of SynGAP (S783A) andPDZGEF1 (5xA)
similarly reduced sGluA1/A2 levels but blocked the additional
loss of surface AMPARs by PTX. Thus, Plk2 phosphorylation of
theseRas/Rap regulators is required for PTX-induceddownregu-
lation of surface AMPARs in proximal dendrites.
Disrupted Ras and Rap Signaling in DN-Plk2 Mice
To study the role of Plk2 in vivo, we generated transgenic (TG)
mice that express dominant negative (DN) kinase-dead Plk2 in
the postnatal forebrain (Figure 8A) via the CaMKIIa promoter
(Mayford et al., 1996). After identification of DN-Plk2 lines by
PCR genotyping (Figure 8B), in situ hybridization revealed trans-
gene mRNA specifically in the adult DN-Plk2 forebrain, in
a pattern similar to the endogenous Plk2 mRNA (Figure 8C).
Native Plk2 protein was weakly detectable by immunohisto-
chemistry in WT mice, while high levels of Plk2 (probably
DN-Plk2) were observed in TG hippocampus and cortex
(Figure 8D). Western-blot analysis showed that expression of
DN-Plk2 was250% of endogenous Plk2 in TGmice (Figure 8E;
p < 0.05). The expression pattern of transgene suggested
DN-Plk2 may effectively compete with and inhibit native Plk2,
as it does in heterologous cells and neurons (Figure S1E and
Figure 2F).
Immunoblotting of forebrain lysates showed no differences in
total expression of several synaptic proteins between genotypes; Table S1).
r conditions were compared to Plk2.
munocytochemistry for GFP. Scale bar represents 5 mm.
*p < 0.001).
; Table S1).
LL3.7), while other conditions were compared to Plk2 RNAi.
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Figure 6. Phosphomutation of Ras/Rap Regulators Prevents Overactivity-Dependent Spine Remodeling
(A) Schematic of phosphomutants used: RasGRF1 (S71A), SynGAP (S390A or S783A), and quintuple PDZGEF1 mutant (5xA).
(B–I) Hippocampal neurons (DIV19) were transfected with pEGFP and either WT or phosphomutant constructs. After 48 hr, neurons were treated with PTX
or vehicle, followed by immunostaining for GFP. Scale, 5 mm.
(J) Quantification of spine density from (B)–(I) (n = 8–11, *p < 0.05, **p < 0.01, ***p < 0.001).
(K–M) Cumulative frequency plot of spine head width (n = 150–200 spines; K-S test; Table S1).
All error bars represent SEM.
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Regulation of Ras and Rap Signaling by Plk2(Figure S7A). However, DN-Plk2 mice expressed higher levels of
RasGRF1 and SPAR compared to WT animals (Figures 8H and
8I), suggesting an imbalance between Ras and Rap in TG966 Neuron 69, 957–973, March 10, 2011 ª2011 Elsevier Inc.mice. Pull-down assays to measure active Ras, Rap1, and
Rap2 showed that DN-Plk2 mice contained greater Ras activity
than WT littermates and, most remarkably, nearly a complete
Neuron
Regulation of Ras and Rap Signaling by Plk2absence of active Rap1 or Rap2 (Figures 8F and 8G), resulting in
40-fold decrease in relative activity of Rap to Ras (p < 0.001).
Additionally, levels of phospho-ERK and GluA1, proteins down-
stream of Ras, were significantly higher in DN-Plk2 mice (Figures
8H and 8I). However, phospho-p38 levels were unchanged,
consistent with DN-Plk2 expression in cultured neurons (Fig-
ure S3F), suggesting the involvement of Rap-independent
pathways in p38 activation. Thus, sustained disruption of Plk2
function hyperactivates Ras and impairs basal Rap signaling in
mouse forebrain.
Altered Spine Morphology in DN-Plk2 Mice
DN-Plk2 brain exhibited no gross anatomical defects (Fig-
ure S7B), although TGmice did exhibit slightly increased cortical
thickness compared to WT animals (Figures S7C–S7E). Golgi
staining showed that pyramidal neurons in hippocampal area
CA1, a region with robust DN-Plk2 expression (Figures 8C and
8D), had significantly more and larger spines in proximal
dendrites of DN-Plk2 mice, but no change in spine length
(Figures 8J–8M; Table S1). The change in spine structure were
confined to proximal dendritic regions with no differences in
distal dendrites (Figures S7F–S7I). Thus, disruption of Ras/Rap
signaling by DN-Plk2 altered cortical structure and increased
spine size and number in vivo.
Aberrant Memory Formation in DN-Plk2 Mice
To investigate whether dysregulation of Plk2 affected learning
and memory, we tested spatial working memory on the T maze
(see Experimental Procedures). Both WT and DN-Plk2 mice
showed normal spontaneous alternation (80%), an innate
behavior dependent on the hippocampus (Lalonde, 2002), with
similar latency to choose either arm, suggesting intact working
memory and exploratory behavior of DN-Plk2 mice (Figures 8N
and 8O).
We next tested long-term spatial memory using the Morris
water maze. Animals received four trials a day over six days,
during which we observed no difference in latency to find the
hidden platform between genotypes (Figure 8P). However, in
the probe trial conducted 48 hr after the last training session,
DN-Plk2 mice spent less time in the target quadrant compared
to WT aniamls, at a level not significantly different from random
chance (25% in each quadrant) (Figure 8Q), indicating impair-
ment of memory retention.
Finally, we performed fear conditioning, a type of long-term
memory task that involves both hippocampus and amygdala.
Mice were conditioned with two tone-shock pairings. Before
training, baseline freezing was similar between genotypes
(2%) (Figure 8R). Freezing was measured after 24 hr in the
same context in which training occurred. Interestingly, DN-Plk2
mice froze significantly more than WT animals (Figure 8R) in
this contextual paradigm. We also tested cued fear memory by
exposing the mice to the tone in a novel context 48 hr after
training. Compared to low levels of pretone freezing in WT
mice, TG mice showed markedly increased pretone freezing
(Figure 8S), suggesting DN-Plk2 mice had higher generalized
fear levels after training irrespective of context. There was no
difference in post-tone freezing between genotypes (Figure 8S).
Importantly, no significant difference was observed in shocksensitivity between genotypes (data not shown), excluding the
possibility that the observed effects in DN-Plk2 mice were due
to greater pain sensation. Together, these behavioral data indi-
cate that disruption of Plk2 impairs proper memory formation
as well as the setting of appropriate fear level.
DISCUSSION
We have demonstrated that Plk2 coordinates the balance
between Ras and Rap to downregulate synapses following
chronic overactivity, and that this regulation is mediated by
direct phosphorylation of an ensemble of Ras/Rap regulators—
SPAR, RasGRF1, SynGAP, and PDZGEF1. We cannot rule out,
however, the possibility that Plk2 may influence other GEFs/
GAPs as well. Phosphorylation of SynGAP required the PBD of
Plk2, which is also required formaximal efficiency of SPARphos-
phorylation (Seeburg et al., 2008). Thus, in the brain the PBD
appears to be a module that targets Plk2 preferentially to
substrates involved in control of Ras and Rap. Although not an
exhaustive approach, the striking result that only Ras/Rap regu-
lators were found to be positive phosphorylation substrates
implicates Plk2 as a central component for controlling Ras and
Rap signaling machinery.
Inhibition of Ras and Activation of Rap by Plk2
Plk2 is required for homeostatic downregulation of excitatory
synaptic activity in hippocampal neurons in a SPAR and Cdk5-
dependent manner (Seeburg et al., 2008). Based on the current
work, we propose the following model for Plk2 function (Fig-
ure S7J): synaptic activity induces expression of Plk2, which
coordinately targets via PBD interactions to key regulators of
Ras and Rap. Phosphorylation-dependent degradation of
RasGRF1 (Ras activator), together with activation of SynGAP
(Ras inhibitor), dramatically reduces active Ras levels.
Conversely, degradation of SPAR (Rap inhibitor) and activation
of PDZGEF1 (Rap activator) work additively to stimulate Rap.
The result of this mirror-image regulatory program is a profound
shift in favor of Rap at the expense of Ras. Indeed, quantification
under various conditions of synaptic activity (or Plk2 function)
revealed that Ras and Rap can be bidirectionally regulated by
Plk2 over 4000-fold difference in relative ratio of Rap to Ras
activation state (Figure S7K). Thus, we propose that Plk2 abun-
dance may act as a graded sensor coupling synaptic activity
level to the fine-tuning of Ras and Rap balance over a wide
dynamic range.
Plk2-Directed Spine Remodeling via Cooperative Action
of Ras/Rap Regulators
In hippocampal neurons, silencing of Plk2 led to more and larger
spines, consistent with a normal function for Plk2 in promoting
spine shrinkage and loss (Pak and Sheng, 2003). These effects
were also observed in hippocampus of DN-Plk2 mice. Impor-
tantly, PTX-mediated reduction of spine density and head width
were abolished by blocking Plk2 activity using multiple indepen-
dentmethods. Therefore, Plk2 is required for homeostatic down-
regulation of dendritic spines in response to chronic overactivity.
Individual knockdown experiments as well as a series of epis-
tasis tests demonstrated that each identified GAP/GEF actedNeuron 69, 957–973, March 10, 2011 ª2011 Elsevier Inc. 967
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Control+PTX Control+PTX Control+PTX Control+PTX
BI 2536 PTX BI 2536 PTX+ + BI 2536+PTX BI 2536+PTX
Plk2 RNAi Plk2 RNAi Plk2 RNAi Plk2 RNAi
Plk2 RNAi+PTX Plk2 RNAi+PTX Plk2 RNAi+PTX Plk2 RNAi+PTX
RasGRF1 RNAi RasGRF1 RNAi
SPAR RNAi SPAR RNAi
SynGAP RNAi+PTX SynGAP RNAi+PTX
PDZGEF1 RNAi+PTX PDZGEF1 RNAi+PTX
GFP GFP+PTX GFP GFP+PTX
RasGRF1 WT RasGRF1 WT+PTX RasGRF1 WT RasGRF1 WT+PTX
RasGRF1 S71A RasGRF1 S71A+PTX RasGRF1 S71A RasGRF1 S71A+PTX
SynGAP WT SynGAP WT+PTX SynGAP WT SynGAP WT+PTX
SynGAP S783A SynGAP S783A+PTX SynGAP S783A SynGAP S783A+PTX
PDZGEF1 WT PDZGEF1 WT+PTX PDZGEF1 WT PDZGEF1 WT+PTX
PDZGEF1 5xA PDZGEF1 5xA+PTX PDZGEF1 5xA PDZGEF1 5xA+PTX
Figure 7. Plk2 phosphorylation of Ras/Rap regulators is required for overactivity-induced downregulation of surface AMPARs
(A and B) Hippocampal neurons (DIV19) were transfected with Plk2-shRNA or control vector (pLL3.7) and treated with or without PTX in the presence of BI2536
or vehicle. Immunostaining is shown for surface GluA1 or GluA2 in proximal and distal dendrites as indicated. Scale, 5 mm.
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Regulation of Ras and Rap Signaling by Plk2downstream of Plk2 in controlling different aspects of dendritic
spines. RasGRF1 consistently increased spine density but also
affected spine length and width in some assays. In contrast,
PDZGEF1 selectively suppressed spine density. SynGAP
reduced spine width, consistent with larger spines observed in
SynGAP-deficient mice (Vazquez et al., 2004), while SPAR
strongly increased head size along with exerting modest effects
on spine density. These results suggest that, despite some
overlap in function, each regulator fulfills a primary responsibility
in homeostatic spine regulation, with RasGRF1 antagonistic to
PDZGEF1 in controlling spine density and SPAR opposing
SynGAP in spine size control (Figure S7L). These observations
may explain the necessity of regulating both Ras and Rap
signaling arms by Plk2. An alternative, but not mutually exclu-
sive, possibility is that Plk2 actions onmultiple GAPs/GEFs allow
synergistic shifts in Ras and Rap balance.
Plk2-Directed Phosphorylation of Ras/Rap Regulators
and Functional Implications
A detailed mechanistic examination of Plk2 phosphorylation
sites on Ras/Rap regulators identified several phosphosites
whose functional influence can be classified into three broad
categories: (1) RasGRF1 phosphorylation sites were found in
PH domains, which suggests involvement in regulating subcel-
lular distribution. We propose that PH domain phosphorylation
by Plk2 leads to detachment from membranes, potentially
increasing accessibility to proteasomal degradation. (2) Phos-
phorylation of both PDZGEF1 and SynGAP induced large gel
mobility shifts suggestive of extensive conformational changes.
Because these alterations were associated with increased enzy-
matic activity, we suggest phosphorylation at these sites locks
SynGAP or PDZGEF1 in an open, active conformation. (3) Addi-
tional phosphosites within or near the GAP domain of SynGAP
(S326, S390) did not appear to be involved in conformational
changes but did interfere with Plk2 ability to modulate SynGAP
enzymatic activity, suggesting an independent mode of regula-
tion that may involve direct GAP domain control.
Importantly, expression of Plk2 phosphorylation-deficient
mutants of RasGRF1, SynGAP, and PDZGEF1 abolished
specific aspects of PTX-induced spine remodeling generally
consistent with knockdown and overexpression studies, demon-
strating that Plk2 phosphorylation of these Ras/Rap regulators is
required for full homeostatic regulation of dendritic spines.
Spatial and Subunit-Specific Regulation
of Surface AMPARs
Overactivity-induced removal of sGluA1 was restricted to prox-
imal dendrites and dependent on Plk2 kinase activity, mirroring
RasGRF1/SPAR expression and dendritic spine loss. In contrast,(C and D) Quantification of integrated intensity for surface GluA1 (C) and GluA2 (D
versus distal control).
(E and G) Neurons were transfected as indicated, treated with PTX or vehicle, an
(F and H) Quantification of integrated intensity for surface GluA1 (F) and GluA2 (H
(I and J) Neurons were transfected with pEGFP and either wild-type or phosphomu
by immunostaining for surface GluA1 and GluA2. Scale, 5 mm.
(K and L) Quantification of integrated intensity for surface GluA1 (K) and GluA2 (L)
+++p < 0.001 versus -PTX).
All error bars represent SEM.hyperexcitation reduced sGluA2 in both proximal and distal
dendrites through a Plk2 kinase-dependent and -independent
mechanism, respectively. These results confirm and extend
our previous findings that a kinase-independent interaction of
Plk2 with NSF dislodges GluA2, causing loss of surface expres-
sion in secondary dendrites (Evers et al., 2010). Although it is
currently unclear how these two mechanisms act on different
dendritic subregions, these findings may suggest that GluA1
and GluA2 subserve distinct functions during homeostatic adap-
tation to overexcitation and support the idea that proximal
dendrites employ a different or additional homeostatic mecha-
nism from distal dendrites (Figure S7J).
A Proximal Dendritic Homeostatic Domain Controlled
by Plk2
Multiple mechanisms of homeostatic synaptic plasticity exist
based on mode of activity manipulation, developmental stage,
and cell type (Pozo and Goda, 2010). Here we elucidated two
distinct and complementary mechanisms of homeostasis de-
pending on dendritic locus as well as Plk2 kinase activity (Fig-
ure S7J), with the following lines of evidence: Plk2 is induced in
a proximal-to-distal gradient by chronic overactivity (Pak and
Sheng, 2003). Plk2 kinase activity was required for depletion of
RasGRF1/SPAR, PSD scaffold proteins, dendritic spines, as
well as sGluA1/A2 specifically within the proximal dendrite. In
contrast, PTX-induced sGluA2 removal in distal dendrites was
kinase independent. These results may reflect a need to regulate
distal AMPARs via a graded, linear response in proportion to the
level of synaptic activity experienced, but to control proximal
dendritic synapses in an all-or-none fashion, potentially in
response to more traumatic or persistent insults. Previous
studies support the idea that homeostatic responses are spatially
restricted. For example, CaMKIIbmRNA is strikingly restricted to
the soma and proximal dendrites (Martone et al., 1996) and its
protein expression is dynamically regulated in homeostatic plas-
ticity (Thiagarajan et al., 2002). AMPA-induced AMPAR internali-
zation also occurs primarily in soma and proximal dendrites of
hippocampal neurons (Biou et al., 2008). Together, these findings
suggest a role of the proximal dendrite as a homeostatic domain
and also emphasize the importance of specifying the dendritic
subregion studied in homeostatic plasticity. This caveat may
explain, at least in part, discrepancies in the literature regarding
AMPAR subunits involved in homeostatic regulation.
Essential In Vivo Requirement for Plk2 Function
in Ras/Rap Regulation
The function of Plk2 in vivo has been explored previously using
knockout animals, but not examined in synaptic plasticity (Inglis
et al., 2009; Ma et al., 2003a). We used a dominant-negative) (n = 10–15, *p < 0.05, **p < 0.01 versus proximal control; +p < 0.05, 2+p < 0.01
d immunolabeled for surface GluA1 and GluA2. Scale, 5 mm.
) (n = 10–15, *p < 0.05, **p < 0.01).
tant constructs. After 48 hr, neurons were treated with PTX or vehicle, followed
(n = 10–15, *p < 0.05, **p < 0.01, ***p < 0.001 versus GFP; +p < 0.05, 2+p < 0.01,
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Figure 8. Altered Ras and Rap Signaling, Spine Morphogenesis, and Impaired Memory in DN-Plk2 Mice
(A) Schematic representation of DN-Plk2 transgene (TG) construct. Gray bar, myc-epitope tag. Black bar, TG-specific in situ hybridization probe.
(B) PCR genotyping of TG mice.
(C) In situ hybridization of mRNA for transgenic and endogenous Plk2.
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by binding to all shared targets of the Plk subfamily and inactivat-
ing them by sequestration. However, it is highly likely that Plk2 is
the relevant polo family kinase involved in activity-dependent
homeostatic synaptic downregulation, based on the similar
effect of Plk2 RNAi on spines in cultured neurons to DN-Plk2 ex-
pressed in TG animals, the absence of Plk1 and Plk4 expression
in normal brain tissue (Winkles and Alberts, 2005), and lack of
effect of Plk3 RNAi on PTX-induced homeostatic plasticity in
any of our assays. The precise function of Plk3 in brain is
unknown, but as this kinase was originally identified as an
FGF-inducible factor, Plk3 may be responsive to neurotrophic
or other growth factor stimulation.
DN-Plk2 animals exhibited increases in RasGRF1 and SPAR
protein levels, similar to expression of DN-Plk2 in dissociated
neuron culture. These effects were accompanied by elevated
levels of active Ras and several phenotypes consistent with
previously described consequences of Ras overactivity including
increased ERK activation, slightly enlarged cortex (probably due
to neuronal hypertrophy) (Heumann et al., 2000), higher spine
density (Arendt et al., 2004), and elevated GluA1 expression
(Kim et al., 2003). Perhaps the most striking observation was
that TG forebrains had nearly undetectable levels of active
Rap1 or Rap2. Thus, Plk2 appears to be critically required for
Rap activation in the brain, at least under basal conditions of
normal ongoing activity. It is nevertheless probable that Plk2-
independent pathways to Ras and Rap regulation exist, particu-
larly under conditions of acute plasticity or stimulation (Woolfrey
et al., 2009).
Physiological Roles of Plk2 In Vivo
Ras signaling plays critical roles in learning and memory
(Mazzucchelli and Brambilla, 2000). Somewhat surprisingly,
DN-Plk2 mice exhibited normal working memory and no deficit
in acquisition of the Morris water maze task. However, TG
mice showed slightly impaired memory retention when sub-
jected to probe tests. Ras/Rap activity (or more likely, the
balance between the two) may play direct roles in memory
mechanisms, as H-Ras knockout mice exhibit enhanced LTP
(Manabe et al., 2000), and Rap1N17 (dominant negative) ex-
pressing mice demonstrate deficient LTP (Morozov et al.,
2003). Alternatively, homeostatic function may be permissive
for effective expression of Hebbian plasticity, as inactivation of(D) Immunohistochemistry of TG and WT brain sections (higher-magnification im
(E) Western-blot analysis of forebrain extracts. Transgene band (arrow) is larger
(F) Pull-down of active Ras, Rap1, and Rap2 in brain lysates from WT and DN-P
(G) Quantification of active Ras, Rap1, and Rap2 normalized to total expression
(H) Immunoblotting of forebrain lysates from WT and DN-Plk2 mice against prote
(I) Quantification of data from (H) normalized to b-actin or total ERK (n = 5–10, *p
(J) Proximal dendritic segments from hippocampal CA1 pyramidal neurons. Spin
Scale, 5 mm.
(K–M) Quantification of spine density (K), head width (L), and length (M) (n = 6, **
(N and O) Spontaneous alternation of WT and DN-Plk2 mice (n = 6) in the T maz
(P and Q) Morris water maze test (n = 6). Latency to find the platform (P) was recor
(*p < 0.05). Dashed line indicates chance level of quadrant exploration time. T, ta
(R and S) Fear conditioning. Mice were conditioned with two tone-shock pairing, t
TG, n = 7; **p < 0.01).
All error bars represent SEM.Plk2 causes run-up of synaptic transmission in hippocampal
slices that prevents induction of subsequent LTP (Seeburg and
Sheng, 2008).
A more pronounced behavioral outcome was uncovered
during cued fear conditioning, which revealed that DN-Plk2
mice experienced similar basal fear compared to WT animals,
but failed to restrain their fear levels after tone-shock pairing.
This result could explain the apparently enhanced freezing
behavior in the contextual fear conditioning. Together, our
behavioral results indicate that imbalance of Ras and Rap by
Plk2 interference is detrimental for stabilization of memory and
setting of fear levels within an appropriate range.
It is worth noting that the Plk2 kinase-independent pathway
could explain some of the phenotypes of the DN-Plk2 TGmouse,
which is impaired for the kinase-dependent pathway but not the
effects of Plk2 on NSF. Thus, the DN-Plk2 mice would be ex-
pected to exhibit a mixed phenotype: loss of some sGluA2 and
synapse weakening through the kinase-independent mecha-
nism, together with a gain of dendritic spines and increased
Ras signaling due to impaired Plk2 kinase-dependent pathways.
In general, however, the biochemical, morphological, and
behavioral phenotypes reported (more and larger spines,
enlarged cortex, increased RasGRF1 and SPAR levels,
increased Ras activity, and elevated fear) were not consistent
with loss of functional GluA2, but rather are better explained by
interference with Plk2 kinase function. These phenotypes
suggest that the kinase-dependent pathway may be the domi-
nant mechanism in these mice. However, the unexpectedly
minor deficits in the water maze test and the lack of seizure
sensitivity (data not shown) in these animals suggest that
weakening of synapses with GluA2 removal may have partially
compensated for the run-up in excitatory synapse size and
number due to loss of Plk2 negative homeostatic function,
leading to potentially less severe hyperactivity and learning
phenotypes than with complete loss of Plk2 expression.
Although we proposed that Plk2 operates over a wide
spectrum of activity levels, it seems plausible that its dampening
influence would be most critically needed during episodes of
extreme overactivity. Thus, homeostatic restraint of heightened
synaptic activity following the strongest forms of environmental
stimuli may represent scenarios in which Plk2-mediated control
of Ras and Rap in proximal dendrites is most relevant and
valuable for animal behavior.ages shown at bottom).
than endogenous Plk2 (arrowhead) due to additional myc epitope.
lk2 mice using GST-Raf1-RBD and GST-RalGDS-RBD.
(n = 5, **p < 0.01, ***p < 0.001).
ins indicated at right of blots.
< 0.05, **p < 0.01).
es were quantified separately on apical oblique (AO) and basal (BS) dendrites.
p < 0.01; head width, K-S test, p < 0.001).
e, quantified by latency to select an arm (N) and percent alternation (O).
ded as index of learning, and probe test (Q) was performed 2 days after training
rget; R, right, O, opposite, and L, left of target.
hen tested for contextual fear (R) at 24 hr and cued fear (S) at 48 hr (WT, n = 10;
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Plk2 Kinase Assay
GST-tagged Plk2 mutants (KD or CA) expressed in COS-7 cells were coupled
to glutathione-Sepharose beads (Amersham Biosciences) and washed in
kinase buffer (50 mM Tris [pH 7.5], 10 mM MgCl2, 5 mM DTT, 2 mM EGTA,
and 2 mM microcystin LR). Candidate substrates expressed in COS-7 cells
were immunoprecipitated and incubated with either KD or CA Plk2 in the pres-
ence of 50 mM ATP and 10 mCi of 32P-g-ATP (6000 Ci/mmol, Amersham) for
30 min at 30C with continuous agitation in a Thermomixer (Eppendorf).
Samples were subjected to SDS-PAGE and gels dried for autoradiography.
Active Ras and Rap Pull-down Assay
Transfected COS-7 cells or cultured hippocampal neurons were harvested in
lysis buffer (25 mM Tris-HCl [pH 7.4], 250 mM NaCl, 0.5% NP40, 1.25 mM
MgCl2, and 5% glycerol). Cell lysates or mouse brain homogenates were
centrifuged, and supernatants were incubated with 20 ml of GST-Raf1-RBD
or GST-RalGDS-RBD coupled to glutathione sepharose (Amersham) for 3 hr
at 4C. Pellets were washed three times in 0.5 ml lysis buffer and analyzed
by western blotting. Additional detailed methods can be found in the Supple-
mental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.neuron.2011.02.004.
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